Proceedings of the 2014 6th International Advanced Research Workshop on in Silico Oncology and Cancer Investigation - The CHIC 2014
DOI: 10.1109/iarwisoci.2014.7034630
|View full text |Cite
|
Sign up to set email alerts
|

Computational horizons in cancer (CHIC): Developing meta- and hyper-multiscale models and repositories for in Silico Oncology - A brief technical outline of the project

Abstract: This paper briefly outlines the aim, the objectives, the architecture and the main building blocks of the ongoing large scale integrating transatlantic research project CHIC (http://chic-vph.eu/).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
3
1
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 4 publications
0
10
0
Order By: Relevance
“…Clinically-driven in silico multi-scale cancer models simulate in vivo tumor growth and response to therapies across biocomplexity scales, within a clinical environment, towards evaluating efficacious treatment combinations. To facilitate the development of multiscale cancer models, several large-scale program projects have been launched (Supplementary Table 12) such as Advancing Clinico-Genomic Trials on Cancer (ACGT) (312), Clinically Oriented Translational Cancer Multilevel Modeling (ContraCancrum) (313), Personalized Medicine (pmedicine) (314), Transatlantic Tumor Model Repositories (TUMOR) (315), and Computational Horizons In Cancer (CHIC) (316), amongst others (Figure 5). Here, we review and evaluate five salient projects for multi-scale cancer modeling towards their clinical deployment.…”
Section: Pipelining Panomics Data Towards In Silico Clinical Systems Oncologymentioning
confidence: 99%
See 1 more Smart Citation
“…Clinically-driven in silico multi-scale cancer models simulate in vivo tumor growth and response to therapies across biocomplexity scales, within a clinical environment, towards evaluating efficacious treatment combinations. To facilitate the development of multiscale cancer models, several large-scale program projects have been launched (Supplementary Table 12) such as Advancing Clinico-Genomic Trials on Cancer (ACGT) (312), Clinically Oriented Translational Cancer Multilevel Modeling (ContraCancrum) (313), Personalized Medicine (pmedicine) (314), Transatlantic Tumor Model Repositories (TUMOR) (315), and Computational Horizons In Cancer (CHIC) (316), amongst others (Figure 5). Here, we review and evaluate five salient projects for multi-scale cancer modeling towards their clinical deployment.…”
Section: Pipelining Panomics Data Towards In Silico Clinical Systems Oncologymentioning
confidence: 99%
“…Another transatlantic project Computational Horizons In Cancer (CHIC) project (316) launched in 2013, aimed to provide an oncosimulator modeling platform for in silico oncology. CHIC was initiated to develop and implement predictive oncology and individualized multi-scale cancer modeling tools towards assisting quantitative cancer research and personalized cancer therapy.…”
Section: Chic Projectmentioning
confidence: 99%
“…In order to demonstrate the capabilities of IAPETUS to cooperate with external data sources and exchange data as needed, the nephro blastoma high-end use case, as defined in MyHealth-Avatar, 29,30 required the establishment of a collaboration with the Computational Horizons in Cancer (CHIC) project. 5 The nephroblastoma Oncosimulator needs preprocessed imaging data to operate. 17,18 To meet this demand, IAPETUS was linked to a clinical data repository developed to hold the data used in CHIC, 31 which acts as one of the third-party sources of data.…”
Section: Json Content Is Sent Through a Validator To Make The Proper Indentationsmentioning
confidence: 99%
“…4 Appropriate reuse of already existing elementary biomodels has led to the creation of complex and highly refined models known as hypermodels. 5 A long-term goal of in silico or computational medicine is to provide clinicians with as many validated and clinically meaningful models as possible so that they can be efficiently supported in their decision-making procedure. Achieving such a goal involves a large number of stakeholders at different time points of a model life cycle.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation